About Reta-Max-20 Retarutide
Take advantage of the affordable Reta-Max-20 Retarutide, a monumental breakthrough in metabolic research. This unprecedented triple agonist harnesses the lustrous power of Retatrutide to offer a 20 mg strength per vial, conveniently packed in a 200 mg kit containing 10 vials. It features a white and green label and comes as a lyophilized powder, soluble in water for injection use. Offered in clinical-grade quality and housed in carton box packaging, Reta-Max-20 stands at the forefront of metabolic disease studies and research innovation.
Specifically Designed for Metabolic Research
Reta-Max-20 Retarutide excels in metabolic disease studies, leveraging its triple receptor agonist action (GIP, GLP-1, GCG) to target crucial metabolic pathways. Its material features include research/clinical grade Retatrutide, a highly purified, lyophilized powder for reliable results. This product's application areas extend to advanced metabolic research and studies conducted in authorized laboratories, exclusively available for use under the direction of qualified healthcare professionals.
Robust Packaging and Global Market Reach
Reta-Max-20 Retarutide is securely dispatched in a carton box with distinctive white and green labeling, reflecting its market value while ensuring product integrity during exchange. Each kit contains 10 vials, catering to substantial research needs. As a valued offering from India, it serves main export markets both domestically and internationally, with shipments handled through major FOB ports to support widespread scientific advancement.
FAQ's of Reta-Max-20 Retarutide:
Q: How should Reta-Max-20 Retarutide be stored for optimal stability?
A: Reta-Max-20 Retarutide should be stored below 25C and protected from light to maintain its quality and effectiveness.
Q: What is the main usage of Reta-Max-20 Retarutide in research?
A: This product is primarily used in metabolic disease research due to its potent triple receptor agonist mechanism, aiding studies on metabolic pathways.
Q: When is a prescription required for Reta-Max-20 Retarutide?
A: A prescription is mandatory, as Reta-Max-20 is designated for research or clinical use and should only be administered by healthcare professionals.
Q: Where is Reta-Max-20 Retarutide manufactured and exported from?
A: Reta-Max-20 Retarutide is supplied and traded from India, with export capabilities to various international markets.
Q: What makes the triple agonist action of Reta-Max-20 Retarutide unprecedented?
A: Its simultaneous GIP, GLP-1, and GCG receptor targeting offers a robust mechanism for comprehensive metabolic research, making it a monumental tool in the field.